Skip to content

RA Capital Nexus Fund, L.P., Director at Artiva Biotherapeutics, bought ARTV on Jul 31, 2026

Data as of Oct 16

▲ BUY$248K24,944 shares at $9.93RA Capital Nexus Fund, L.P. DirectorARTV Artiva Biotherapeutics, Inc.
Watch ARTV
Traded
Jul 31, 2026
Disclosed
Jul 31, 2026
Filed
The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

RA Capital Nexus Fund, L.P., Director at Artiva Biotherapeutics, bought ARTV on Jul 31, 2026TRADEDDISCLOSED
ARTVSimilar stocks (XLV — its sector index fund), rebased to ARTV's price on the disclosure day
ARTV since disclosure
−42.1%
Similar stocks (XLV) since disclosure
+8.7%
XLV — its sector index fund

Change in closing price from Jul 31, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▲ BUYRA Capital Nexus Fund III, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$248Kdisclosed Jul 31 · filed the same day
  2. ▲ BUYPeter Kolchinsky DirectorARTV Artiva Biotherapeutics, Inc.$248Kdisclosed Jul 31 · filed the same day
  3. ▲ BUYRA Capital Healthcare Fund LP DirectorARTV Artiva Biotherapeutics, Inc.$248Kdisclosed Jul 31 · filed the same day
  4. ▲ BUYRajeev M. Shah DirectorARTV Artiva Biotherapeutics, Inc.$248Kdisclosed Jul 31 · filed the same day
  5. ▲ BUYRa Capital Management, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$248Kdisclosed Jul 31 · filed the same day
  6. ▲ BUYRA Capital Nexus Fund, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$208Kdisclosed Jul 31 · filed 2 days after the trade
  7. ▲ BUYRajeev M. Shah DirectorARTV Artiva Biotherapeutics, Inc.$208Kdisclosed Jul 31 · filed 2 days after the trade
  8. ▲ BUYRA Capital Nexus Fund III, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$208Kdisclosed Jul 31 · filed 2 days after the trade
  9. ▲ BUYRA Capital Healthcare Fund LP DirectorARTV Artiva Biotherapeutics, Inc.$208Kdisclosed Jul 31 · filed 2 days after the trade
  10. ▲ BUYRa Capital Management, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$208Kdisclosed Jul 31 · filed 2 days after the trade
  11. ▲ BUYPeter Kolchinsky DirectorARTV Artiva Biotherapeutics, Inc.$208Kdisclosed Jul 31 · filed 2 days after the trade

See every trade on ARTV →